Predictive value of phenotypic variables for skin cancer: Risk assessment beyond skin typing

International Journal of Dermatology

Volumn 45, Issue 11, 2006, Pages 1275-1283

  Xu, Lisa Y ^a   Koo, John ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAMNESIS; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; FAMILY HISTORY; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HUMAN; MELANOMA; MORBIDITY; PHENOTYPE; PREDICTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SKIN CANCER; SKIN CARCINOGENESIS; SKIN EXAMINATION; SKIN PIGMENTATION; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; ULTRAVIOLET RADIATION;

HUMANS; MELANOMA; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; SKIN PIGMENTATION; SUNBURN; SUNLIGHT;

EID: 33750622305     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2006.02999.x     Document Type: Review

References (28)

1. Stern RS, Lange R. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after treatment. J Invest Dermatol 1988; 91: 120-124.
2. Stern RS, PUVA Follow-Up Study. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 2001; 44: 755-761.
3. Lindelof B, Sigurgeirsson B, Tegner E, et al. PUVA and cancer risk: The Swedish follow-up study. Br J Dermatol 1999; 141: 108-112.
4. Lee E, Koo J, Berger T. UVB phototherapy and skin cancer risk: A review of the literature. Int J Dermatol 2005; 44: 355-360.
5. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124: 869-871.
6. Stern RS, Momtaz K. Skin typing for assessment of skin cancer risk and acute response to UV-B and oral methoxsalen photochemotherapy. Arch Dermatol 1984; 120: 869-873.
7. Lock-Andersen J, Wulf HC, Knudstorp ND. Interdependence of eye and hair colour, skin type and skin pigmentation in a Caucasian population. Acta Derm Venereol 1998; 78: 214-219.
8. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 2005; 41: 28-44.
9. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005.
10. Cho E, Rosner BA, Feskanich D, et al. Risk factors and individual probabilities of melanoma for whites. J Clin Oncol 2005; 23: 2669-2675.
11. Bliss JM, Ford D, Swerdlow AJ, et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE). Int J Cancer 1995; 62: 367-376.
12. van Dam RM, Huang Z, Rimm EB, et al. Risk factors for basal cell carcinoma of the skin in men: Results from the health professionals follow-up study. Am J Epidemiol 1999; 150: 459-468.
13. Hunter DJ, Colditz GA, Stampfer MJ, et al. Risk factors for basal cell carcinoma in a prospective cohort of women. Ann Epidemiol 1990; 1: 13-23.
14. Lear JT, Tan BB, Smith AG, et al. Risk factors for basal cell carcinoma in the UK: Case-control study in 806 patients. J R Soc Med 1997; 90: 371-374.
15. Walther U, Kron M, Sander S, et al. Risk and protective factors for sporadic basal cell carcinoma: Results of a two-centre case-control study in southern Germany. Clinical actinic elastosis may be a protective factor. Br J Dermatol 2004; 151: 170-178.
16. Corona R, Dogliotti E, D'Errico M, et al. Risk factors for basal cell carcinoma in a Mediterranean population: Role of recreational sun exposure early in life. Arch Dermatol 2001; 137: 1162-1168.
17. Lock-Andersen J, Drzewiecki KT, Wulf HC. Eye and hair colour, skin type and constitutive skin pigmentation as risk factors for basal cell carcinoma and cutaneous malignant melanoma: A Danish case-control study. Acta Derm Venereol 1999; 79: 74-80.
18. Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 1995; 131: 157-163.
19. Grodstein F, Speizer FE, Hunter DJ. A prospective study of incident squamous cell carcinoma of the skin in the nurses' health study. J Natl Cancer Inst 1995; 87: 1061-1066.
20. English DR, Armstrong BK, Kricker A, et al. Demographic characteristics, pigmentary and cutaneous risk factors for squamous cell carcinoma of the skin: A case-control study. Int J Cancer 1998; 76: 628-634.
21. Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma. Arch Dermatol 1995; 131: 164-169.
22. Zanetti R, Rosso S, Martinez C, et al. The multicentre south European study "Helios". I: Skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin. Br J Cancer 1996; 73: 1440-1446.
23. Kricker A, Armstrong BK, English DR, et al. Pigmentary and cutaneous risk factors for non-melanocytic skin cancer - a case-control study. Int J Cancer 1991; 48: 650-662.
24. Sturm RA. Skin colour and skin cancer - MC1R, the genetic link. Melanoma Res 2002; 12: 405-416.
25. Rosso S, Zanetti R, Martinez C, et al. The multicentre south European study "Helios". II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer 1996; 73: 1447-1454.
26. Beaumont KA, Newton RA, Smit DJ, et al. Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk. Hum Mol Genet 2005; 14: 2145-2154.
27. Sanchez-Laorden BL, Sanchez-Mas J, Martinez-Alonso E, et al. Dimerization of the human melanocortin 1 receptor: Functional consequences and dominant-negative effects. J Invest Dermatol 2006; 126: 172-181.
28. Rosso S, Minarro R, Schraub S, et al. Reproducibility of skin characteristic measurements and reported sun exposure history. Int J Epidemiol 2002; 31: 439-446.